Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
about
Antidotes for acute cardenolide (cardiac glycoside) poisoningAvailability of antidotes at acute care hospitals in OntarioEpidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka.Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.Proarrhythmia, a serious complication of antiarrhythmic drugs.Treatment of congestive heart failure--current status of use of digitoxin.Antidote use in the critically ill poisoned patient.Acute plant poisoning and antitoxin antibodies.Engineered antibodies as pharmacological tools.Editorial: Antidotes and rescue therapies.Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels.Digitalis toxicity. Using immunotherapy when supportive care isn't enough.Digoxin-specific antibody fragments: how much and when?Utility of the electrocardiogram in drug overdose and poisoning: theoretical considerations and clinical implications.Digoxin intoxication: An old enemy in modern eraSuccessful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature.Mechanisms, manifestations, and management of digoxin toxicity in the modern era.The safety of digoxin as a pharmacological treatment of atrial fibrillation.Pharmacotherapy considerations in advanced cardiac life support.Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report.Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitisRetrospective evaluation of patients with elevated digoxin levels at an emergency department.Prognostic utility of serum potassium in chronic digoxin toxicity: a case-control study.Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.Emergency management and resuscitation of poisoned patients: perspectives from "down under".Accidental digitoxin intoxication: an interplay between laboratory and clinical medicine.Management of atrial fibrillation in critically ill patients.Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan.Retrospective review of digoxin exposures to a poison control system following recall of Digitek® tablets.Management of cardiac arrest following poisoning.Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.Recrudescent digoxin toxicity treated with plasma exchange: a case report and review of literature.Hypocalcaemia after an occult calcium channel blocker overdose: a case report and literature review.Digoxin-specific antibody fragments in the treatment of digoxin toxicity.Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system.Diagnosis and treatment of digoxin toxicity.Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup.Life-threatening digoxin toxicity due to drug-drug interactions in an HIV-positive man.Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).Reduction of toxicity of a vinca alkaloid by an anti-vinca alkaloid antibody.
P2860
Q24243807-2C48D879-6DF6-470D-A461-07AB6617A788Q28344796-2015349A-7A3E-4FD1-8D7E-117D68696AE7Q33864049-0764C741-3D3A-425A-BB55-3030474EDA5AQ33930768-BC1D6B99-7D0C-45EC-B52D-9F55A4EBFF41Q34027347-0659FD47-8A5E-4CDB-BE4B-646FE500BBE7Q34088364-98FF1377-FA6E-40F0-9AAA-956425AFF6B7Q34562529-E51BC357-978B-46FA-9902-7DBF939F971AQ35154681-A591C42D-B581-4244-ADF9-5616CD45A901Q35180023-783781E7-7BD2-46B7-8670-151DA8799FC6Q35966123-399269FA-6428-4519-92B2-E13DD3DD24F5Q36066317-7B44F01B-00F0-48EF-90EE-C9D4A4C49E32Q36082378-B8E34D3B-DDFB-43D1-A4C5-F06B8A49EE7CQ36110937-D3F8ADFC-F978-406E-8D14-4D433FDDD614Q36120716-AC7F0602-E880-454C-A3A2-B6518D24E23FQ36313646-1F82FD41-10AA-4917-B335-E78F3017ACA1Q36355378-40A1A979-7E8A-4DBF-A76B-B7D2B37F1C54Q36429334-B1A163BC-9FA9-40ED-A2CC-B213CFD0FD25Q36446911-BE1F454A-9DDB-45A1-A8D7-A21A774ABDC1Q36662909-7E1E1FE7-81E1-4BFA-AF10-0F99CBA5D791Q36723478-35FBA696-F21E-49ED-BB41-30A9837D51B4Q36830128-00733A7C-BF31-4915-878E-4D32ED8D3E84Q36940549-22623B9B-7110-4A52-B414-06788FA3AEAFQ37126374-D1FD6747-285F-46DC-9B5D-A208ABB3EB86Q37128780-33C88256-C8B2-43CB-8DAF-C64D9B5D29BBQ37325378-6E1D5CC9-1009-42A1-A440-9661846DE5F2Q37508378-B58782F6-F808-4506-A2E6-E9F888087C84Q37556650-F6124A00-6932-4D75-8758-93917BA11541Q37581834-5DD9A3E1-3F80-47CC-BC8D-0671110B414FQ37775004-ED1A6063-2EB0-46F7-9F41-7230A01A78D5Q37834087-33E89BE0-A825-49D9-991A-87CC62C5E2C8Q37982782-02EADF26-6167-453C-B733-09800ABB012AQ38012358-CA2D1F13-812A-425E-A2E0-06A4408BEBEAQ38137315-BBBC9FF0-2F8F-4155-9FC4-4A678EB82687Q38236647-765648B6-D86D-4522-BD74-871CD3B24B9BQ38323258-DA8E727D-0882-4110-B0DC-CA87362DD58DQ38662296-512AA596-38B2-4C79-B71C-F28AF847C497Q38706177-5CD7AEB5-81E8-4A34-9622-1160F4BBADF1Q38839462-2BB3E536-1E19-4836-BAFD-F4EA61533DF4Q39818756-CE109DB3-A53F-45BB-BFDE-6CDFD4B0BC4DQ41399894-B3C54C03-3E90-46D1-9BD9-7D8CF45C9612
P2860
Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Treatment of 150 cases of life ...... report of a multicenter study.
@ast
Treatment of 150 cases of life ...... report of a multicenter study.
@en
Treatment of 150 cases of life ...... report of a multicenter study.
@nl
type
label
Treatment of 150 cases of life ...... report of a multicenter study.
@ast
Treatment of 150 cases of life ...... report of a multicenter study.
@en
Treatment of 150 cases of life ...... report of a multicenter study.
@nl
prefLabel
Treatment of 150 cases of life ...... report of a multicenter study.
@ast
Treatment of 150 cases of life ...... report of a multicenter study.
@en
Treatment of 150 cases of life ...... report of a multicenter study.
@nl
P2093
P921
P356
P1433
P1476
Treatment of 150 cases of life ...... report of a multicenter study.
@en
P2093
P304
P356
10.1161/01.CIR.81.6.1744
P407
P577
1990-06-01T00:00:00Z